A Synaptic Mechanism Underlying the Behavioral Abnormalities Induced by Manganese Intoxication

In the present study we have characterized a rat model of manganese (Mn) intoxication leading to behavioral disinhibition in the absence of major motor alterations. These behavioral changes were associated with significantly increased brain Mn levels but were uncoupled to anatomical lesions of the striatum or to morphological and cytochemical changes of the nigrostriatal dopaminergic pathway. The analysis of this model at cellular level showed an enhanced dopaminergic inhibitory control of the corticostriatal excitatory transmission via presynaptic D2-like dopamine (DA) receptors in slices obtained from Mn-treated rats. Conversely, the use of agonists acting on presynaptic purinergic, muscarinic, and glutamatergic metabotropic receptors revealed a normal sensitivity. Moreover, membrane responses recorded from single dopaminergic neurons following activation of D2 DA autoreceptors were also unchanged following Mn intoxication. Thus, our findings indicate a selective involvement of the D2-like DA receptors located on glutamatergic corticostriatal terminals in this pathological condition and suggest that the behavioral symptoms described in the "early" clinical phase of manganism may be caused by an abnormal dopaminergic inhibitory control on corticostriatal inputs. The identification of the synaptic mechanism underlying the "early" phase of Mn intoxication might have a critical importance to understand the causes of the progression of this pathological condition towards an "established" phase characterized by motor abnormalities and anatomical lesions of the basal ganglia.

[1]  P. Calabresi,et al.  Physiology and pharmacology of dopamine D2‐receptors , 1989, Neurology.

[2]  C. Marsden,et al.  Dual task performance and processing resources in normal subjects and patients with Parkinson's disease. , 1991, Brain : a journal of neurology.

[3]  G C COTZIAS,et al.  Manganese in health and disease. , 1958, Physiological reviews.

[4]  P. Calabresi,et al.  Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice. , 1997, Neuroscience.

[5]  N. Chu,et al.  Manganism and idiopathic parkinsonism , 1994, Neurology.

[6]  Gunnar F. Nordberg,et al.  Handbook on the Toxicology of Metals , 1979 .

[7]  J. Walsh Depression of excitatory synaptic input in rat striatal neurons , 1993, Brain Research.

[8]  N. Chu,et al.  Long-term progression in chronic manganism , 1998, Neurology.

[9]  R. Kawamura,et al.  Intoxication by Manganese in Well Water. , 1941 .

[10]  P. Calabresi,et al.  Endogenous Adenosine Mediates the Presynaptic Inhibition Induced by Aglycemia at Corticostriatal Synapses , 1997, The Journal of Neuroscience.

[11]  G Bernardi,et al.  Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease. , 1993, Brain : a journal of neurology.

[12]  P. Calabresi,et al.  Activation of Group III Metabotropic Glutamate Receptors Depresses Glutamatergic Transmission at Corticostriatal Synapse , 1997, Neuropharmacology.

[13]  T. Kita,et al.  Passive electrical membrane properties of rat neostriatal neurons in an in vitro slice preparation , 1984, Brain Research.

[14]  C. Rossi-Arnaud,et al.  Radial maze performance and open-field behaviours in aged C57BL/6 mice: Further evidence for preserved cognitive abilities during senescence , 1994, Physiology & Behavior.

[15]  C. W. Olanow,et al.  Manganese intoxication in the rhesus monkey , 1996, Neurology.

[16]  G Maura,et al.  Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals. , 1988, The Journal of pharmacology and experimental therapeutics.

[17]  J. Kebabian,et al.  Biochemical changes accompanying unilateral 6-hydroxydopamine lesions in the rat substantia nigra , 1978, Brain Research.

[18]  W. C. Cooper The health implications of increased manganese in the environment resulting from the combustion of fuel additives: a review of the literature. , 1984, Journal of toxicology and environmental health.

[19]  D. Johnston,et al.  Changes in paired-pulse facilitation suggest presynaptic involvement in long-term potentiation , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[20]  B. Snow,et al.  Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication , 1997, Neurology.

[21]  M C Newland,et al.  Animal models of manganese's neurotoxicity. , 1999, Neurotoxicology.

[22]  T. Robbins,et al.  A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. , 1988, Brain : a journal of neurology.

[23]  P. Calabresi,et al.  Abnormal Synaptic Plasticity in the Striatum of Mice Lacking Dopamine D2 Receptors , 1997, The Journal of Neuroscience.

[24]  P. Calabresi,et al.  Unilateral dopamine denervation blocks corticostriatal LTP. , 1999, Journal of neurophysiology.

[25]  N Meadows,et al.  Manganese toxicity in children receiving long-term parenteral nutrition , 1996, The Lancet.

[26]  G Bernardi,et al.  Synaptic and intrinsic control of membrane excitability of neostriatal neurons. I. An in vivo analysis. , 1990, Journal of neurophysiology.

[27]  C. Martínez,et al.  Manganese intoxication and chronic liver failure , 1994, Annals of Neurology.

[28]  Gregory G. Brown,et al.  Occupational exposures to metals as risk factors for Parkinson's disease , 1997, Neurology.

[29]  J RODIER,et al.  Manganese Poisoning in Moroccan Miners , 1955, British journal of industrial medicine.

[30]  D. Lovinger,et al.  Short- and long-term synaptic depression in rat neostriatum. , 1993, Journal of neurophysiology.

[31]  R. Nicoll,et al.  Modulation of synaptic transmission and long-term potentiation: effects on paired pulse facilitation and EPSC variance in the CA1 region of the hippocampus. , 1993, Journal of neurophysiology.

[32]  P. Calabresi,et al.  Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission , 1992, Annals of neurology.

[33]  A. Carlsson,et al.  Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease , 1990, Trends in Neurosciences.

[34]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[35]  P. Calabresi,et al.  Blockade of M2‐like muscarinic receptors enhances long‐term potentiation at corticostriatal synapses , 1998 .

[36]  M. Beal,et al.  Manganese Injection into the Rat Striatum Produces Excitotoxic Lesions by Impairing Energy Metabolism , 1993, Experimental Neurology.

[37]  P. Calabresi,et al.  Long-term synaptic depression in the striatum: physiological and pharmacological characterization , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[38]  P. Calabresi,et al.  The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia , 1996, Trends in Neurosciences.

[39]  Bernard Pillon,et al.  Cognitive deficits in Parkinson’s disease , 1996, Journal of Neurology.

[40]  Jordan Grafman,et al.  Handbook of Neuropsychology , 1991 .

[41]  N. Mercuri,et al.  Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. , 1987, The Journal of physiology.

[42]  G C Cotzias,et al.  Chronic manganese poisoning , 1969, Neurology.

[43]  H C Merchant,et al.  Chronic manganese poisoning. , 1967, Journal of postgraduate medicine.

[44]  P. Calabresi,et al.  Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: Implications for ischemia and Huntington's disease , 1998, Annals of neurology.

[45]  D. Perl,et al.  MRI and PET studies of manganese‐intoxicated monkeys , 1995, Neurology.

[46]  A. Barbeau,et al.  Role of manganese in dystonia. , 1976, Advances in neurology.